2010
DOI: 10.1007/s00228-010-0926-y
|View full text |Cite
|
Sign up to set email alerts
|

Different effects of tocolytic medication on blood pressure and blood pressure amplification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 54 publications
0
1
1
Order By: Relevance
“…The prodrug was safe and well tolerated across all dosing regimens. Significant changes in vital signs were not observed in this trial, despite the previously reported blood pressure elevation in response to topical application of FP agonists [41] and the association of tocolytic medication with hypotensive effects [42,43]. After oral administration, the prodrug was readily transformed into its metabolite OBE002.…”
Section: Discussioncontrasting
confidence: 54%
“…The prodrug was safe and well tolerated across all dosing regimens. Significant changes in vital signs were not observed in this trial, despite the previously reported blood pressure elevation in response to topical application of FP agonists [41] and the association of tocolytic medication with hypotensive effects [42,43]. After oral administration, the prodrug was readily transformed into its metabolite OBE002.…”
Section: Discussioncontrasting
confidence: 54%
“…[10] We evaluated the acute effects of therapeutic doses of ritodrine and atosiban on blood pressure, cardiac function, micro-circulation (total peripheral resistance) and macro-circulation (large artery stiffness) in healthy non-pregnant female volunteers.…”
Section: Introductionmentioning
confidence: 99%